Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | IC50 | 16.0 [1], 46.0 [2] | |
| 3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)benzamide | IC50 | 1.2 [1], 2.0 [2] | |
| 4-(2-Fluoro-4-iodoanilino)-1-methyl-6-oxopyridine-3-carboxamide | IC50 | 4.0 [1], 23.0 [2] | |
| 3,4-Difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide | IC50 | 17.4 [1], 30.0 [2] | |
| 4-(2-Fluoro-4-iodoanilino)-6-oxo-1-propylpyridine-3-carboxamide | IC50 | 430.0 [1], 2540.0 [2] | |
MLA | "Quest Database™ Dual specificity mitogen-activated protein kinase kinase; MEK1/2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/dual-specificity-mitogen-activated-protein-kinase-kinase-mek1-2-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 15). Quest Database™ Dual specificity mitogen-activated protein kinase kinase; MEK1/2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-mitogen-activated-protein-kinase-kinase-mek1-2-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |